ASH Education Book 2009

^[31]Retrouvez l’ASH education book 2009 en cliquant sur le lien ou l’image sur les sessions éducationnelles du congrès de l’ASH qui s’est tenu en décembre 2009.

Les archives des précédentes années sont également disponibles gratuitement.

Lien : http://asheducationbook.hematologylibrary.org/ ^[31]

Table des matières

^[32]

Mel Greaves

Darwin and evolutionary tales in leukemia
Hematology 2009:3-12. [Abstract] ^[33] [Full Text] ^[34] [PDF] ^[35]

^[32]

Mark A. Crowther

Introduction to surrogates and evidence-based mini-reviews
Hematology 2009:15-16. [Full Text] ^[36] [PDF] ^[37]

^[32]

Carolyn C. Hoppe

Newborn screening for non-sickling hemoglobinopathies
Hematology 2009:19-25. [Abstract] ^[38] [Full Text] ^[39] [PDF] ^[40]

Suthat Fucharoen and Vip Viprakasit

Hb H disease: clinical course and disease modifiers
Hematology 2009:26-34. [Abstract] ^[41] [Full Text] ^[42] [PDF] ^[43]

Elliott P. Vichinsky

Alpha thalassemia major—new mutations, intrauterine management, and outcomes
Hematology 2009:35-41. [Abstract] ^[44] [Full Text] ^[45] [PDF] ^[46]

^[32]

Joshua J. Field and Michael R. DeBaun

Asthma and sickle cell disease: two distinct diseases or part of the same process?
Hematology 2009:45-53. [Abstract] ^[47] [Full Text] ^[48] [PDF] ^[49]

Kenneth I. Ataga

Novel therapies in sickle cell disease
Hematology 2009:54-61. [Abstract] ^[50] [Full Text] ^[51] [PDF] ^[52]

Russell E. Ware and Banu Aygun

Advances in the use of hydroxyurea
Hematology 2009:62-69. [Abstract] ^[53] [Full Text] ^[54] [PDF] ^[55]

^[32]

George Garratty

Drug-induced immune hemolytic anemia
Hematology 2009:73-79. [Abstract] ^[56] [Full Text] ^[57] [PDF] ^[58]

Philip C. Hoffman

Immune hemolytic anemia—selected topics
Hematology 2009:80-86. [Abstract] ^[59] [Full Text] ^[60] [PDF] ^[61]

Kasturi Haldar and Narla Mohandas

Malaria, erythrocytic infection, and anemia
Hematology 2009:87-93. [Abstract] ^[62] [Full Text] ^[63] [PDF] ^[64]

^[32]

Paula H. B. Bolton-Maggs

Factor XI deficiency—resolving the enigma?
Hematology 2009:97-105. [Abstract] ^[65] [Full Text] ^[66] [PDF] ^[67]

J. Evan Sadler

Low von Willebrand factor: sometimes a risk factor and sometimes a disease
Hematology 2009:106-112. [Abstract] ^[68] [Full Text] ^[69] [PDF] ^[70]

Francesco Rodeghiero, Giancarlo Castaman, and Alberto Tosetto

Optimizing treatment of von Willebrand disease by using phenotypic and molecular data
Hematology 2009:113-123. [Abstract] ^[71] [Full Text] ^[72] [PDF] ^[73]

^[32]

Alexandra H. Filipovich

Hemophagocytic lymphohistiocytosis (HLH) and related disorders
Hematology 2009:127-131. [Abstract] ^[74] [Full Text] ^[75] [PDF] ^[76]

Adrian J. Thrasher

New insights into the biology of Wiskott-Aldrich syndrome (WAS)
Hematology 2009:132-138. [Abstract] ^[77] [Full Text] ^[78] [PDF] ^[79]

Luigi D. Notarangelo

Primary immunodeficiencies (PIDs) presenting with cytopenias
Hematology 2009:139-143. [Abstract] ^[80] [Full Text] ^[81] [PDF] ^[82]

^[32]

Kenneth Kaushansky

Determinants of platelet number and regulation of thrombopoiesis
Hematology 2009:147-152. [Abstract] ^[83] [Full Text] ^[84] [PDF] ^[85]

James N. George and Richard H. Aster

Drug-induced thrombocytopenia: pathogenesis, evaluation, and management
Hematology 2009:153-158. [Abstract] ^[86] [Full Text] ^[87] [PDF] ^[88]

Radek C. Skoda

Thrombocytosis
Hematology 2009:159-167. [Abstract] ^[89] [Full Text] ^[90] [PDF] ^[91]

^[32]

Marion E. Reid

Transfusion in the age of molecular diagnostics
Hematology 2009:171-177. [Abstract] ^[92] [Full Text] ^[93] [PDF] ^[94]

Stella T. Chou and Connie M. Westhoff

Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease
Hematology 2009:178-184. [Abstract] ^[95] [Full Text] ^[96] [PDF] ^[97]

Davor Brinc and Alan H. Lazarus

Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn
Hematology 2009:185-191. [Abstract] ^[98] [Full Text] ^[99] [PDF] ^[100]

^[32]

Gordon D. McLaren and Victor R. Gordeuk

Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study
Hematology 2009:195-206. [Abstract] ^[101] [Full Text] ^[102] [PDF] ^[103]

An-Sheng Zhang and Caroline A. Enns

Molecular mechanisms of normal iron homeostasis
Hematology 2009:207-214. [Abstract] ^[104] [Full Text] ^[105] [PDF] ^[106]

Roland Fischer and Paul R. Harmatz

Non-invasive assessment of tissue iron overload
Hematology 2009:215-221. [Abstract] ^[107] [Full Text] ^[108] [PDF] ^[109]

^[32]

Thomas L. Ortel

Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation
Hematology 2009:225-232. [Abstract] ^[110] [Full Text] ^[111] [PDF] ^[112]

Wendy Lim

Antiphospholipid antibody syndrome
Hematology 2009:233-239. [Abstract] ^[113] [Full Text] ^[114] [PDF] ^[115]

Craig S. Kitchens

Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)
Hematology 2009:240-246. [Abstract] ^[116] [Full Text] ^[117] [PDF] ^[118]

Ara Metjian and Wendy Lim

ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
Hematology 2009:247-249. [Abstract] ^[119] [Full Text] ^[120] [PDF] ^[121]

Adam Cuker and Thomas L. Ortel

ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?
Hematology 2009:250-252. [Abstract] ^[122] [Full Text] ^[123] [PDF] ^[124]

^[32]

Bruce Furie

Pathogenesis of thrombosis
Hematology 2009:255-258. [Abstract] ^[125] [Full Text] ^[126] [PDF] ^[127]

David Green

Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism
Hematology 2009:259-266. [Abstract] ^[128] [Full Text] ^[129] [PDF] ^[130]

David Varon and Galia Spectre

Antiplatelet agents
Hematology 2009:267-272. [Abstract] ^[131] [Full Text] ^[132] [PDF] ^[133]

Natalie S. Evans and David Green

ASH evidence-based guidelines: statins in the prevention of venous thromboembolism
Hematology 2009:273-274. [Abstract] ^[134] [Full Text] ^[135] [PDF] ^[136]

^[32]

Andra H. James

Pregnancy-associated thrombosis
Hematology 2009:277-285. [Abstract] ^[137] [Full Text] ^[138] [PDF] ^[139]

Rita Selby and William Geerts

Prevention of venous thromboembolism: consensus, controversies, and challenges
Hematology 2009:286-292. [Abstract] ^[140] [Full Text] ^[141] [PDF] ^[142]

Brett L. Cucchiara

Evaluation and management of stroke
Hematology 2009:293-301. [Abstract] ^[143] [Full Text] ^[144] [PDF] ^[145]

Anita Rajasekhar and Mark A. Crowther

ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients?
Hematology 2009:302-304. [Abstract] ^[146] [Full Text] ^[147] [PDF] ^[148]

^[32]

Kara M. Kelly

Integrative therapies for children with hematological malignancies
Hematology 2009:307-312. [Abstract] ^[149] [Full Text] ^[150] [PDF] ^[151]

Daniel Man-Yuen Sze and Godfrey Chi-Fung Chan

Supplements for immune enhancement in hematologic malignancies
Hematology 2009:313-319. [Abstract] ^[152] [Full Text] ^[153] [PDF] ^[154]

Volker Diehl

The bridge between patient and doctor: the shift from CAM to integrative medicine
Hematology 2009:320-325. [Abstract] ^[155] [Full Text] ^[156] [PDF] ^[157]

^[32]

Akiko Shimamura

Clinical approach to marrow failure
Hematology 2009:329-337. [Abstract] ^[158] [Full Text] ^[159] [PDF] ^[160]

Rodrigo T. Calado

Telomeres and marrow failure
Hematology 2009:338-343. [Abstract] ^[161] [Full Text] ^[162] [PDF] ^[163]

Christoph Klein

Congenital neutropenia
Hematology 2009:344-350. [Abstract] ^[164] [Full Text] ^[165] [PDF] ^[166]

^[32]

Adolfo A. Ferrando

The role of NOTCH1 signaling in T-ALL
Hematology 2009:353-361. [Abstract] ^[167] [Full Text] ^[168] [PDF] ^[169]

Mark R. Litzow

Evolving paradigms in the therapy of Philadelphia chromosome–negative acute lymphoblastic leukemia in adults
Hematology 2009:362-370. [Abstract] ^[170] [Full Text] ^[171] [PDF] ^[172]

Oliver G. Ottmann and Heike Pfeifer

Management of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph⁺ ALL)
Hematology 2009:371-381. [Abstract] ^[173] [Full Text] ^[174] [PDF] ^[175]

^[32]

David Grimwade and Robert K. Hills

Independent prognostic factors for AML outcome
Hematology 2009:385-395. [Abstract] ^[176] [Full Text] ^[177] [PDF] ^[178]

Jacob M. Rowe

Optimal induction and post-remission therapy for AML in first remission
Hematology 2009:396-405. [Abstract] ^[179] [Full Text] ^[180] [PDF] ^[181]

Stephen J. Forman

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?
Hematology 2009:406-413. [Abstract] ^[182] [Full Text] ^[183] [PDF] ^[184]

Monica S. Thakar and Stephen J. Forman

ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?
Hematology 2009:414-418. [Abstract] ^[185] [Full Text] ^[186] [PDF] ^[187]

^[32]

Tait D. Shanafelt

Predicting clinical outcome in CLL: how and why
Hematology 2009:421-429. [Abstract] ^[188] [Full Text] ^[189] [PDF] ^[190]

Andy C. Rawstron

Monoclonal B-cell lymphocytosis
Hematology 2009:430-439. [Abstract] ^[191] [Full Text] ^[192] [PDF] ^[193]

Michael Hallek

State-of-the-art treatment of chronic lymphocytic leukemia
Hematology 2009:440-449. [Abstract] ^[194] [Full Text] ^[195] [PDF] ^[196]

^[32]

John M. Goldman

Initial treatment for patients with CML
Hematology 2009:453-460. [Abstract] ^[197] [Full Text] ^[198] [PDF] ^[199]

Dale Bixby and Moshe Talpaz

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance
Hematology 2009:461-476. [Abstract] ^[200] [Full Text] ^[201] [PDF] ^[202]

Timothy P. Hughes and Susan Branford

Monitoring disease response to tyrosine kinase inhibitor therapy in CML
Hematology 2009:477-487. [Abstract] ^[203] [Full Text] ^[204] [PDF] ^[205]

^[32]

Ralf Küppers

Molecular biology of Hodgkin lymphoma
Hematology 2009:491-496. [Abstract] ^[206] [Full Text] ^[207] [PDF] ^[208]

John Kuruvilla

Standard therapy of advanced Hodgkin lymphoma
Hematology 2009:497-506. [Abstract] ^[209] [Full Text] ^[210] [PDF] ^[211]

Anas Younes

Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
Hematology 2009:507-519. [Abstract] ^[212] [Full Text] ^[213] [PDF] ^[214]

^[32]

Elaine S. Jaffe

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research
Hematology 2009:523-531. [Abstract] ^[215] [Full Text] ^[216] [PDF] ^[217]

Steven H. Bernstein and W. Richard Burack

The incidence, natural history, biology, and treatment of transformed lymphomas
Hematology 2009:532-541. [Abstract] ^[218] [Full Text] ^[219] [PDF] ^[220]

Martin Dreyling, Wolfgang Hiddemann for The European MCL Network

Current treatment standards and emerging strategies in mantle cell lymphoma
Hematology 2009:542-551. [Abstract] ^[221] [Full Text] ^[222] [PDF] ^[223]

^[32]

Jesús F. San-Miguel and María-Victoria Mateos

How to treat a newly diagnosed young patient with multiple myeloma
Hematology 2009:555-565. [Abstract] ^[224] [Full Text] ^[225] [PDF] ^[226]

Antonio Palumbo and Francesca Gay

How to treat elderly patients with multiple myeloma: combination of therapy or sequencing
Hematology 2009:566-577. [Abstract] ^[227] [Full Text] ^[228] [PDF] ^[229]

A. Keith Stewart

Novel therapies for relapsed myeloma
Hematology 2009:578-586. [Abstract] ^[230] [Full Text] ^[231] [PDF] ^[232]

Irene M. Ghobrial and A. Keith Stewart

ASH evidence-based guidelines: what is the role of maintenance therapy in the treatment of multiple myeloma?
Hematology 2009:587-589. [Abstract] ^[233] [Full Text] ^[234] [PDF] ^[235]

^[32]

Anthony H. Goldstone and Jacob M. Rowe

Transplantation in adult ALL
Hematology 2009:593-601. [Abstract] ^[236] [Full Text] ^[237] [PDF] ^[238]

Peter Dreger

Allotransplantation for chronic lymphocytic leukemia
Hematology 2009:602-609. [Abstract] ^[239] [Full Text] ^[240] [PDF] ^[241]

Koen van Besien

Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy
Hematology 2009:610-618. [Abstract] ^[242] [Full Text] ^[243] [PDF] ^[244]

^[32]

Philip A. Beer and Anthony R. Green

Pathogenesis and management of essential thrombocythemia
Hematology 2009:621-628. [Abstract] ^[245] [Full Text] ^[246] [PDF] ^[247]

Mary Frances McMullin

Idiopathic erythrocytosis: a disappearing entity
Hematology 2009:629-635. [Abstract] ^[248] [Full Text] ^[249] [PDF] ^[250]

Srdan Verstovsek

Therapeutic potential of JAK2 inhibitors
Hematology 2009:636-642. [Abstract] ^[251] [Full Text] ^[252] [PDF] ^[253]

^[32]

David P. Steensma

The changing classification of myelodysplastic syndromes: what’s in a name?
Hematology 2009:645-655. [Abstract] ^[254] [Full Text] ^[255] [PDF] ^[256]

Mikkael A. Sekeres

Treatment of MDS: something old, something new, something borrowed…
Hematology 2009:656-663. [Abstract] ^[257] [Full Text] ^[258] [PDF] ^[259]

Heather A. Leitch and Linda M. Vickars

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
Hematology 2009:664-672. [Abstract] ^[260] [Full Text] ^[261] [PDF] ^[262]

^[32]

Malcolm K. Brenner and Fatma V. Okur

Overview of gene therapy clinical progress including cancer treatment with gene-modified T cells
Hematology 2009:675-681. [Abstract] ^[263] [Full Text] ^[264] [PDF] ^[265]

Alessandro Aiuti and Maria Grazia Roncarolo

Ten years of gene therapy for primary immune deficiencies
Hematology 2009:682-689. [Abstract] ^[266] [Full Text] ^[267] [PDF] ^[268]

Derek A. Persons

Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders
Hematology 2009:690-697. [Abstract] ^[269] [Full Text] ^[270] [PDF] ^[271]

^[32]

Carl Walkey, Edward A. Sykes, and Warren C. W. Chan

Application of semiconductor and metal nanostructures in biology and medicine
Hematology 2009:701-707. [Abstract] ^[272] [Full Text] ^[273] [PDF] ^[274]

James R. Baker, Jr.

Dendrimer-based nanoparticles for cancer therapy
Hematology 2009:708-719. [Abstract] ^[275] [Full Text] ^[276] [PDF] ^[277]

Andrew Elias and Andrew Tsourkas

Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles
Hematology 2009:720-726. [Abstract] ^[278] [Full Text] ^[279] [PDF] ^[280]

^[32]

Irene M. Ghobrial, Jacob P. Laubach, and Robert J. Soiffer

Finding the right academic job
Hematology 2009:729-733. [Abstract] ^[281] [Full Text] ^[282] [PDF] ^[283]

Andrew I. Schafer

The academic job offer: what to expect and how to negotiate
Hematology 2009:734-735. [Abstract] ^[284] [Full Text] ^[285] [PDF] ^[286]

George R. Buchanan

Academic promotion and tenure: a user’s guide for junior faculty members
Hematology 2009:736-741. [Abstract] ^[287] [Full Text] ^[288] [PDF] ^[289]